
Coronavirus research tools: Cayman Chemical
Identifying drugs and developing rapid and accurate diagnostic tests for SARS-CoV-2 are currently at the…
Identifying drugs and developing rapid and accurate diagnostic tests for SARS-CoV-2 are currently at the…
In an interview with leaders from Bitscopic, we learn about the predictive model, with a machine learning algorithm that they use to predict the diagnostic fingerprint of COVID-19, using standard laboratory tests.
In an exclusive interview with an author behind one of the papers published in the recent Future Virology Special Focus Issue, heptatitis and COVID-19 are discussed.
In this Special Report from the ‘COVID-19: studying the global pandemic’ Special Focus Issue authors theorize about the identification of asymptomatic patients and the impact this has on the spread of COVID-19.
As the coronavirus surges across the globe, diagnostic testing comes into its own, as researchers unite to confront, delay and stop its spread. In the absence of either proven effective therapy or a vaccine, diagnostic testing becomes a valuable tool.
Take a look at the research highlights of 2019 as we count down the top infectious disease stories from A to Z!
The WHO have updated their recommendations on HIV testing in order to try and expand treatment coverage and reach the people living with HIV who are not yet diagnosed.
In 2018 more people received treatment for tuberculosis than ever before, largely due to improvements in detection and diagnosis, according to the latest Global Tuberculosis Report from the WHO.
Take a look at this month’s industry headlines including FDA warnings over hepatitis C drugs in patients with liver injury, a new infectious diseases strategy for the UK and priority review for Merck’s Ebola vaccine.
A novel phage-based blood assay has demonstrated its potential for identifying people at high-risk of developing tuberculosis, in addition to diagnosing established cases.